Helpdesk

Sales contact

Home > eConsent

eConsent

Infographic

Kayentis and ClinOne combined solution

Improve your eCOA data collection and clinical trial efficiency thanks to Kayentis and ClinOne combined solution! Ease the patient and site journey with a unique access to: eCOA data collection...

Infographic

Unlock additional capabilities for your next clinical trial

eConsent Interoperability

Benefit from the alliance between Kayentis and ClinOne and access to a complete range of capabilities in a powerful, interoperable...

Press Release

Kayentis and ClinOne join forces to improve efficiency and patient experience in clinical trials

eConsent

Alliance merges products and services, gaining patients, sites and sponsors unique access to best-in-class eCOA, eConsent and patient engagement solutions....

Subscribe to our newsletter

Rare disease clinical research: it is time to tackle what...

The client’s voice: why they consistently choose Kayentis

Why you should join Kayentis

Rethinking pediatric clinical trials: guidelines from pediatric experts

Overcoming challenges in long-lasting pediatric clinical trials – Insights from...

Tackling the specificities of NASH/MASH clinical trials

About the author

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.

Kayentis Europe
19 bis, chemin du vieux Chêne
38240 Meylan
France
Phone: +33 (0)4 76 00 54 20

Kayentis US
186 South Street
Suite 600
Boston, Massachusetts 02111
USA